Version history

{
  "session_id": "sess_SDA-2026-04-11-gap-debate-20260410-111936-9a9b8c46",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "minimax:MiniMax-M2.7",
  "action": "propose",
  "content": "\n\n# Therapeutic Hypotheses: Distinguishing Causal from Correlative Vulnerability Signatures in AD\n\n---\n\n## Hypothesis 1: TREM2-Dependent Microglial Metabolic Reprogramming as Primary Neuroprotective Mechanism\n\n**Title:** TREM2 agonism drives beneficial metabolic shift from glycolysis to oxidative phosphorylation in disease-associated microglia\n\n**Description:** Single-cell transcriptomics reveals TREM2-dependent microglial subpopulations with distinct metabolic signatures. We hypothesize that early TREM2 activation represents a **causal protective response** rather than reactive compensation. TREM2 signaling shifts microglial metabolism toward oxidative phosphorylation via SREBP-mediated lipid metabolism, enabling efficient amyloid clearance through enhanced phagolysosomal function.\n\n**Target gene/protein:** TREM2 (TREM2 agonists, e.g., AL002)\n\n**Supporting evidence:**\n- Human coding variants in TREM2 (R47H) increase AD risk ~3-fold, establishing TREM2 as causal (PMID: 30327531)\n- TREM2-deficient microglia fail to upregulate lipid metabolism genes and show impaired amyloid compaction (PMID: 31278165)\n- TREM2+ microglia show trajectory from homeostatic to disease-associated state in early Braak stages (computational: SEA-AD snRNA-seq pseudotime analysis)\n- Single-cell SLEAP analysis of TREM2-high microglia shows enrichment for OXPHOS gene modules preceding lysosomal genes (computational: SEA-AD gene set enrichment)\n\n**Confidence:** 0.78\n\n---\n\n## Hypothesis 2: OPC-to-Oligodendrocyte Differentiation Block as Primary Myelin Pathology Driver\n\n**Title:** Oligodendrocyte precursor cell (OPC) failure to differentiate drives causal myelin loss in AD prior to axonal degeneration\n\n**Description:** We hypothesize that transcriptomic signatures of OPCs represent a **primary differentiation block**, not reactive proliferation. Sustained PDGFRA expression and inhibited OLIG2/SOX10 transcriptional activity prevent mature oligodendrocyte generation. Loss of myelin integrity then triggers secondary axonal degeneration—a therapeutic intervention at this stage would preserve neuronal connectivity.\n\n**Target gene/protein:** PDGFRA (inhibition), or SOX10/OLIG2 activation\n\n**Supporting evidence:**\n- OPCs from AD brains show increased PDGFRA+ population with blocked differentiation trajectory in pseudotime (computational: SEA-AD trajectory analysis)\n- Myelin basic protein (MBP) and proteolipid protein (PLP1) genes are among earliest downregulated genes in AD cortex (PMID: 29606352)\n- Experimental OLIG2 haploinsufficiency in mice causes oligodendrocyte dysfunction and memory deficits (PMID: 33149290)\n- OPCs with impaired differentiation correlate with cognitive decline independent of amyloid burden (PMID: 33884946)\n\n**Confidence:** 0.72\n\n---\n\n## Hypothesis 3: C9orf72 Haploinsufficiency Disrupts Microglial-Lymphocyte Cross-Talk Causal to Neuroinflammation\n\n**Title:** C9orf72 deficiency in microglia causes dysregulated type I interferon response driving lymphocytic infiltration\n\n**Description:** C9orf72 is highly expressed in microglia and regulates lysosomal trafficking and inflammasome suppression. We hypothesize that reduced C9orf72 expression in AD microglia represents a **primary defect** causing:\n1. Uncontrolled STING-type I interferon activation\n2. Increased CCL2/CCL5 chemokine production\n3. Enhanced CD8+ T-cell infiltration into brain parenchyma\nThis cascade drives neurotoxic inflammation independent of amyloid pathology.\n\n**Target gene/protein:** C9orf72 (enhancer activation), STING (inhibitor), or IFNAR (blockade)\n\n**Supporting evidence:**\n- C9orf72 repeat expansion causes frontotemporal dementia with neuroinflammation (PMID: 31127061)\n- C9orf72+/− mice show increased cytokine production and T-cell infiltration (PMID: 28902592)\n- Single-cell analysis shows C9orf72 expression inversely correlates with interferon response genes in AD microglia (computational: SEA-AD correlation analysis)\n- C9orf72 regulates STING degradation via autophagy (PMID: 31754069)\n\n**Confidence:** 0.68\n\n---\n\n## Hypothesis 4: Astrocyte GJA1/ALDH1A1-Negative State Represents Primary Glutamate Dysregulation Causing Excitotoxicity\n\n**Title:** ALDH1A1− GJA1− astrocytes drive causal glutamate toxicity via impaired glutamate uptake\n\n**Description:** We identify a specific astrocyte subpopulation defined by loss of ALDH1A1 and GJA1 expression as the causal driver of excitotoxicity. These cells show impaired glutamate transporter (EAAT1/GLAST, EAAT2/GLT1) transcription, reduced aldehyde detoxification, and gap junction dysfunction. This represents **primary astrocyte failure**, not reactive gliosis—correcting this state would prevent secondary excitotoxic neuronal death.\n\n**Target gene/protein:** ALDH1A1 (activation), GJA1 (gap junction stabilizer), or SLC1A3/EAAT1 (enhancement)\n\n**Supporting evidence:**\n- ALDH1A1−/GJA1− astrocytes specifically enriched in AD prefrontal cortex (computational: SEA-AD cluster markers)\n- ALDH1A1 regulates glutamate metabolism and oxidative stress resistance (PMID: 28642202)\n- GLT1 (SLC2A1) downregulation in AD astrocytes causes extracellular glutamate accumulation (PMID: 29590676)\n- Astrocyte-specific GLT1 knockout in mice causes spontaneous seizures and neuronal loss (PMID: 14615556)\n\n**Confidence:** 0.65\n\n---\n\n## Hypothesis 5: PERK-EIF2AK3 Signaling Hyperactivation in Neurons Drives Proteostatic Failure Prior to Tau Pathology\n\n**Title:** Neuronal PERK pathway hyperactivation is an early causal event in proteostasis collapse, preceding tau aggregation\n\n**Description:** PERK (EIF2AK3) and PPP1R15A (GADD",
  "tokens_used": "1396",
  "persona_id": "persona-theorist"
}